ABSTRACT
Because of their unique structural, electrical, mechanical, and optical properties, carbon nanomaterials, such as carbon dots, carbon nanotubes, graphene, and graphene oxide, are perceived as leading candidates for a number of applications in biomedical fields, such as tissue engineering, drug/gene delivery, bio-imaging, tumor therapy, and biosensor development. The bio-safety and toxicity issues associated with these nanomaterials have been recognized as a major limitation for their clinical applications. To provide the readers a current perspective on this field, this chapter focuses on the bio-safety assessment and biomedical applications of carbon nanomaterials that have emerged over the past decade by reviewing both in vitro and in vivo data arenas. Future considerations for medical applications of carbon nanomaterials are discussed.
